163 related articles for article (PubMed ID: 34288034)
1. Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis.
Hogan AL; Grima N; Fifita JA; McCann EP; Heng B; Fat SCM; Wu S; Maharjan R; Cain AK; Henden L; Rayner S; Tarr I; Zhang KY; Zhao Q; Zhang ZH; Wright A; Lee A; Morsch M; Yang S; Williams KL; Blair IP
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):990-1003. PubMed ID: 34288034
[TBL] [Abstract][Full Text] [Related]
2. Familial ALS-associated
Widagdo J; Udagedara S; Bhembre N; Tan JZA; Neureiter L; Huang J; Anggono V; Lee M
Open Biol; 2022 Sep; 12(9):220187. PubMed ID: 36168806
[TBL] [Abstract][Full Text] [Related]
3. ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.
Rayner SL; Cheng F; Hogan AL; Grima N; Yang S; Ke YD; Au CG; Morsch M; De Luca A; Davidson JM; Molloy MP; Shi B; Ittner LM; Blair I; Chung RS; Lee A
Hum Mol Genet; 2021 May; 30(11):971-984. PubMed ID: 33729478
[TBL] [Abstract][Full Text] [Related]
4. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
[TBL] [Abstract][Full Text] [Related]
5. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS.
Luisier R; Tyzack GE; Hall CE; Mitchell JS; Devine H; Taha DM; Malik B; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
Nat Commun; 2018 May; 9(1):2010. PubMed ID: 29789581
[TBL] [Abstract][Full Text] [Related]
6. Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA.
Snijders AP; Hautbergue GM; Bloom A; Williamson JC; Minshull TC; Phillips HL; Mihaylov SR; Gjerde DT; Hornby DP; Wilson SA; Hurd PJ; Dickman MJ
RNA; 2015 Mar; 21(3):347-59. PubMed ID: 25605962
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models.
van Hummel A; Sabale M; Przybyla M; van der Hoven J; Chan G; Feiten AF; Chung RS; Ittner LM; Ke YD
Neuropathol Appl Neurobiol; 2023 Apr; 49(2):e12902. PubMed ID: 36951214
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation and Dislocation of SFPQ Disturbed DNA Organization in Alzheimer's Disease and Frontotemporal Dementia.
Lu J; Shu R; Zhu Y
J Alzheimers Dis; 2018; 61(4):1311-1321. PubMed ID: 29376859
[TBL] [Abstract][Full Text] [Related]
9. Widespread intron retention impairs protein homeostasis in C9orf72 ALS brains.
Wang Q; Conlon EG; Manley JL; Rio DC
Genome Res; 2020 Dec; 30(12):1705-1715. PubMed ID: 33055097
[TBL] [Abstract][Full Text] [Related]
10. Non-nuclear Pool of Splicing Factor SFPQ Regulates Axonal Transcripts Required for Normal Motor Development.
Thomas-Jinu S; Gordon PM; Fielding T; Taylor R; Smith BN; Snowden V; Blanc E; Vance C; Topp S; Wong CH; Bielen H; Williams KL; McCann EP; Nicholson GA; Pan-Vazquez A; Fox AH; Bond CS; Talbot WS; Blair IP; Shaw CE; Houart C
Neuron; 2017 Apr; 94(2):322-336.e5. PubMed ID: 28392072
[TBL] [Abstract][Full Text] [Related]
11. Aberrant cytoplasmic intron retention is a blueprint for RNA binding protein mislocalization in VCP-related amyotrophic lateral sclerosis.
Tyzack GE; Neeves J; Crerar H; Klein P; Ziff O; Taha DM; Luisier R; Luscombe NM; Patani R
Brain; 2021 Aug; 144(7):1985-1993. PubMed ID: 33693641
[TBL] [Abstract][Full Text] [Related]
12. Prematurely terminated intron-retaining mRNAs invade axons in SFPQ null-driven neurodegeneration and are a hallmark of ALS.
Taylor R; Hamid F; Fielding T; Gordon PM; Maloney M; Makeyev EV; Houart C
Nat Commun; 2022 Nov; 13(1):6994. PubMed ID: 36414621
[TBL] [Abstract][Full Text] [Related]
13. Nuclear RNA foci from
Bajc Česnik A; Darovic S; Prpar Mihevc S; Štalekar M; Malnar M; Motaln H; Lee YB; Mazej J; Pohleven J; Grosch M; Modic M; Fonovič M; Turk B; Drukker M; Shaw CE; Rogelj B
J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30745340
[TBL] [Abstract][Full Text] [Related]
14. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones.
Highley JR; Kirby J; Jansweijer JA; Webb PS; Hewamadduma CA; Heath PR; Higginbottom A; Raman R; Ferraiuolo L; Cooper-Knock J; McDermott CJ; Wharton SB; Shaw PJ; Ince PG
Neuropathol Appl Neurobiol; 2014 Oct; 40(6):670-85. PubMed ID: 24750229
[TBL] [Abstract][Full Text] [Related]
15. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death.
Wen X; Tan W; Westergard T; Krishnamurthy K; Markandaiah SS; Shi Y; Lin S; Shneider NA; Monaghan J; Pandey UB; Pasinelli P; Ichida JK; Trotti D
Neuron; 2014 Dec; 84(6):1213-25. PubMed ID: 25521377
[TBL] [Abstract][Full Text] [Related]
16. An aggregate-inducing peripherin isoform generated through intron retention is upregulated in amyotrophic lateral sclerosis and associated with disease pathology.
Xiao S; Tjostheim S; Sanelli T; McLean JR; Horne P; Fan Y; Ravits J; Strong MJ; Robertson J
J Neurosci; 2008 Feb; 28(8):1833-40. PubMed ID: 18287500
[TBL] [Abstract][Full Text] [Related]
17. [Aberrant Interaction Between FUS and SFPQ in Neurons in a Wide Range of FTLD Spectrum Diseases].
Ishigaki S
Brain Nerve; 2021 Sep; 73(9):1021-1028. PubMed ID: 34462374
[TBL] [Abstract][Full Text] [Related]
18. A conserved role for the ALS-linked splicing factor SFPQ in repression of pathogenic cryptic last exons.
Gordon PM; Hamid F; Makeyev EV; Houart C
Nat Commun; 2021 Mar; 12(1):1918. PubMed ID: 33771997
[TBL] [Abstract][Full Text] [Related]
19. Splicing Players Are Differently Expressed in Sporadic Amyotrophic Lateral Sclerosis Molecular Clusters and Brain Regions.
La Cognata V; Gentile G; Aronica E; Cavallaro S
Cells; 2020 Jan; 9(1):. PubMed ID: 31936368
[TBL] [Abstract][Full Text] [Related]
20. Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis.
Ishihara T; Ariizumi Y; Shiga A; Kato T; Tan CF; Sato T; Miki Y; Yokoo M; Fujino T; Koyama A; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
Hum Mol Genet; 2013 Oct; 22(20):4136-47. PubMed ID: 23740936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
